X-linked lymphoproliferative syndrome 2 is a recessive disorder caused by mutations of the XIAP gene. It is characterized by immunodeficiency in particular against EBV infections.
![]() |
||||
![]() |
![]() |
|||
![]() |
![]() |
|||
![]() |
![]() |
|||
![]() |
![]() |
|||
![]() |
![]() |
![]() ![]() |
||
![]() |
![]() |
![]() |
![]() |
![]() |
1. |
Rigaud S et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. ![]() |
2. |
Worthey EA et al. (2011) Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. ![]() |
3. |
Yang X et al. (2012) Clinical and genetic characteristics of XIAP deficiency in Japan. ![]() |
4. |
Latour S et al. (2015) XIAP deficiency syndrome in humans. ![]() |
5. |
Dziadzio M et al. (2015) Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. ![]() |
6. |
Nishida N et al. (2015) Dysgammaglobulinemia Associated With Glu349del, a Hypomorphic XIAP Mutation. ![]() |
7. |
Zhao M et al. (2010) A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. ![]() |
8. |
Pachlopnik Schmid J et al. (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). ![]() |
10. |
Wikipedia article Wikipedia EN (X-linked_lymphoproliferative_disease)![]() |